|Day Low/High||10.91 / 11.32|
|52 Wk Low/High||10.01 / 31.22|
Investors eyeing a purchase of Insys Therapeutics Inc stock, but tentative about paying the going market price of $12.78/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $9 strike, which has a bid at the time of this writing of 95 cents.
Donald Trump was not the only big winner on Election Day. The cannabis industry got a spark as well.
President-elect Trump's vague healthcare policy has put the $3 trillion industry on edge.
The U.S. president elect has said in the past that he favors the legalization of marijuana, and he is unlikely to change his stance significantly.
Cannabis stocks listed on the Nasdaq continued to rally after voters ended prohibition and approved the recreational use of marijuana in California, Massachusetts, Maine and Nevada.
The volume of cannabis stocks listed on the Nasdaq have spiked ahead of the election as voters decide tomorrow on recreational and medical use of marijuana.
Jim Cramer likes YUM; says STZ is more appetizing than MNST
Index funds are great, Jim Cramer says, but he encourages investors to do some smart stock picking.
Company will request support from Colombia's Ministry of Health.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
Nasdaq-traded marijuana stocks are undervalued as investors remain skittish and the use of drugs produced by these biopharmaceutical companies have not been widely adopted.
Insys Therapeutics (INSY) stock is trading sharply higher this afternoon after receiving FDA approval for Syndros.
Trade-Ideas LLC identified Insys Therapeutics (INSY) as a pre-market mover with heavy volume candidate
Trade-Ideas LLC identified Insys Therapeutics (INSY) as a "dead cat bounce" (down big yesterday but up big today) candidate